Oliver Schmalz

ABVD in Older Patients With Early-Stage Hodgkin Lymphoma Treated Within the German Hodgkin Study Group HD10 and HD11 Trials

Boris Böll, Helen Görgen, Michael Fuchs et al. · Journal of Clinical Oncology · 2013 · 109 citations · Full text

Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study

Michael Thomas, Santiago Ponce-Aix, Alejandro Navarro et al. · Annals of Oncology · 2018 · 80 citations · Full text

Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients

Oliver Schmalz, Christine Jacob, Johannes Ammann et al. · Journal of Medical Internet Research · 2020 · 51 citations · Full text

Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group

Stephanie Sasse, Magdalena Alram, Horst Müller et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 13 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +11

Care for MRSA carriers in the outpatient sector: a survey among MRSA carriers and physicians in two regions in Germany

Heike Raupach-Rosin, Nicole Rübsamen, Sebastian Szkopek et al. · BMC Infectious Diseases · 2016 · 13 citations · Full text